Cite this article
369
Downloads
3
Citations
971
Views
Announcements
Open Access
Review
COVID-19 and myocarditis: a brief review
Fatma Taher1,†, Athar Eysa2,†, Dalia Fahmy3,†, Ahmed Shalaby2, Ali Mahmoud2, Moumen El-Melegy4, Ahmed Abdel Khalek Abdel Razek3, Ayman El-Baz2,*
Show Less
1
The College of Technological Innovation, Zayed University, 19282 Dubai, UAE
2
Bioengineering Department, University of Louisville, Louisville, KY 40292, USA
3
Department of Diagnostic Radiology, Mansoura faculty of medicine, 13551 Mansoura, Egypt
4
Department of Electrical Engineering, Assiut University, 71515 Assiut, Egypt
*Correspondence: aselba01@louisville.edu (Ayman El-Baz)
†These authors contributed equally.
Academic Editor: Graham Pawelec
†These authors contributed equally.
Academic Editor: Graham Pawelec
Front. Biosci. (Landmark Ed) 2022, 27(2), 73;
https://doi.org/10.31083/j.fbl2702073
Submitted: 13 August 2021 | Revised: 14 December 2021 | Accepted: 15 December 2021 | Published: 21 February 2022
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract
Cardiovascular complications (especially myocarditis) related to COVID-19 viral infection are not well understood, nor do they possess a well recognized diagnostic protocol as most of our information regarding this issue was derived from case reports. In this article we extract data from all published case reports in the second half of 2020 to summarize the theories of pathogenesis and explore the value of each diagnostic test including clinical, lab, ECG, ECHO, cardiac MRI and endomyocardial biopsy. These tests provide information that explain the mechanism of development of myocarditis that further paves the way for better management.
Keywords
COVID-19
Myocarditis
SARS-CoV-2
Figures
Fig. 1.